Fighting the Opioid Epidemic with Sunshine Act of 2018
Fighting the Opioid Epidemic with Sunshine Act of 2018
This bill expands Medicaid and Medicare reporting requirements related to the transparency of physician ownership or investment interests.
Under current law, a manufacturer of drugs, devices, or medical supplies that are covered under Medicaid or Medicare must regularly report on any payment or transfer of value by the manufacturer to a “covered recipient,” defined as either a physician who is not an employee of the manufacturer or a teaching hospital. The bill expands the definition of “covered recipient” to also include any of the following practitioners who is not an employee of the manufacturer: (1) a physician assistant, (2) a nurse practitioner, (3) a clinical nurse specialist, (4) a certified registered nurse anesthetist, or (5) a certified nurse-midwife.
Read twice and referred to the Committee on Finance.